Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Global X Genomics & Biotechnology ETF (NQ:GNOM)

45.45 -0.16 (-0.35%)
Streaming Delayed Price Updated: 3:03 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,487
Open 45.51
Bid (Size) 45.37 (200)
Ask (Size) 45.56 (100)
Prev. Close 45.61
Today's Range 45.41 - 45.71
52wk Range 27.20 - 48.09
Shares Outstanding 33,418,720
Dividend Yield 0.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance ↗
Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook. Stock price up 3.06%. 
Via Benzinga
News headline image
3 Gene Editing Stocks with Potential to Transform Medicine ↗
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. 
Via InvestorPlace

Performance

YTD
+15.9%
+15.9%
1 Month
+0.5%
+0.5%
3 Month
+17.0%
+17.0%
6 Month
+34.0%
+34.0%
1 Year
+17.5%
+17.5%

More News

Read More
News headline image
The 3 Best Gene Editing Stocks to Buy in July 2024 ↗
Via InvestorPlace
News headline image
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗
Via InvestorPlace
News headline image
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
Via InvestorPlace
News headline image
ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? ↗
Via Talk Markets
News headline image
3 Stocks That Could Be the Next Big Thing in Gene Editing ↗
Via InvestorPlace
News headline image
3 Gene Editing Stocks With Unprecedented Surge Potential ↗
Via InvestorPlace
News headline image
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗
Via InvestorPlace
News headline image
3 Gene Editing Stocks to Generate Super-Charged Gains ↗
Via InvestorPlace
News headline image
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗
Via InvestorPlace
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
Via InvestorPlace
News headline image
3 Gene Editing Stocks With the Best Long-Term Potential ↗
Via InvestorPlace
News headline image
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years ↗
Via InvestorPlace
News headline image
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗
Via Talk Markets
News headline image
A Comprehensive Guide To Genomic ETFs ↗
Via Talk Markets
News headline image
Top-Performing Biotech ETFs of Last Week ↗
Via Talk Markets

Frequently Asked Questions

Is Global X Genomics & Biotechnology ETF publicly traded?
Yes, Global X Genomics & Biotechnology ETF is publicly traded.
What exchange does Global X Genomics & Biotechnology ETF trade on?
Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Global X Genomics & Biotechnology ETF?
The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market
What is the current price of Global X Genomics & Biotechnology ETF?
The current price of Global X Genomics & Biotechnology ETF is 45.45
When was Global X Genomics & Biotechnology ETF last traded?
The last trade of Global X Genomics & Biotechnology ETF was at 12/31/25 03:03 PM ET
What is the market capitalization of Global X Genomics & Biotechnology ETF?
The market capitalization of Global X Genomics & Biotechnology ETF is 1.52B
How many shares of Global X Genomics & Biotechnology ETF are outstanding?
Global X Genomics & Biotechnology ETF has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.